Yuko Ishii

3.3k total citations
84 papers, 1.5k citations indexed

About

Yuko Ishii is a scholar working on Molecular Biology, Oncology and Epidemiology. According to data from OpenAlex, Yuko Ishii has authored 84 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 15 papers in Oncology and 15 papers in Epidemiology. Recurrent topics in Yuko Ishii's work include Cancer Immunotherapy and Biomarkers (7 papers), Ophthalmology and Visual Impairment Studies (6 papers) and Corneal surgery and disorders (6 papers). Yuko Ishii is often cited by papers focused on Cancer Immunotherapy and Biomarkers (7 papers), Ophthalmology and Visual Impairment Studies (6 papers) and Corneal surgery and disorders (6 papers). Yuko Ishii collaborates with scholars based in Japan, United States and France. Yuko Ishii's co-authors include Sébastien G. Bouret, Takahiro Hiraoka, Tetsuro Oshika, C. Okamoto, Tetsuhiko Kakita, Toni K. Choueiri, Sachet A. Shukla, David A. Braun, Catherine J. Wu and Alice M. Walsh and has published in prestigious journals such as Journal of Clinical Oncology, Journal of Molecular Biology and Cell Metabolism.

In The Last Decade

Yuko Ishii

82 papers receiving 1.5k citations

Peers

Yuko Ishii

EPIDE

ONCOL

PRM

SURGE

Yuki Hattori Japan

Huseyin Mehmet United Kingdom

Fabio Benigni Italy

Yifan Chen China

Lisa Olson United States

Neda Khanlarkhani Iran

Masanori Miyata Japan

Takuya Nishimura Japan

Chikara Shimizu Japan

Yuki Hattori Japan

Yuko Ishii

521 ×1.2

158 ×0.5

EPIDE

182 ×0.6

ONCOL

182 ×0.7

PRM

186 ×0.8

SURGE

Citations per year, relative to Yuko Ishii Yuko Ishii (= 1×) peers Yuki Hattori

Countries citing papers authored by Yuko Ishii

Since Specialization

Citations

This map shows the geographic impact of Yuko Ishii's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuko Ishii with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuko Ishii more than expected).

Fields of papers citing papers by Yuko Ishii

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuko Ishii. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuko Ishii. The network helps show where Yuko Ishii may publish in the future.

Co-authorship network of co-authors of Yuko Ishii

This figure shows the co-authorship network connecting the top 25 collaborators of Yuko Ishii. A scholar is included among the top collaborators of Yuko Ishii based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuko Ishii. Yuko Ishii is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

El-Khoueiry, Anthony B., Tae‐You Kim, Jean‐Frédéric Blanc, et al.. (2024). International, open-label phase 2 study of regorafenib plus pembrolizumab in patients with advanced hepatocellular carcinoma (HCC) previously treated with immune checkpoint inhibitors (ICI).. Journal of Clinical Oncology. 42(16_suppl). 4007–4007. 13 indexed citations

Endo‐Takahashi, Yoko, Yuko Ishii, Nobuhito Hamano, et al.. (2023). Development of a Gene and Nucleic Acid Delivery System for Skeletal Muscle Administration via Limb Perfusion Using Nanobubbles and Ultrasound. Pharmaceutics. 15(6). 1665–1665. 4 indexed citations

Ishii, Yuko, Jinhua Piao, Mitsuko Masutani, et al.. (2023). Targeting Poly(ADP)ribose polymerase in BCR/ABL1-positive cells. Scientific Reports. 13(1). 7588–7588. 2 indexed citations

Ishii, Yuko, et al.. (2023). The Effects of Mucopolysaccharide Polysulfate on Steroid-Induced Tight Junction Barrier Dysfunction in Human Epidermal Keratinocytes and a 3D Skin Model. Skin Pharmacology and Physiology. 36(4). 186–194. 1 indexed citations

Kasuga, Ikuma, et al.. (2022). Monthly Fluctuation of Spike Protein-specific IgG Antibody Level against COVID-19 after COVID-19 Vaccination and Booster Shot. 3(3). 3 indexed citations

Suzuki, Keisuke, Shiho Suzuki, Yuko Ishii, et al.. (2020). Plasma prostaglandin D2 synthase levels in sleep and neurological diseases. Journal of the Neurological Sciences. 411. 116692–116692. 8 indexed citations

Samata, Bumpei, et al.. (2020). L1CAM Is a Marker for Enriching Corticospinal Motor Neurons in the Developing Brain. Frontiers in Cellular Neuroscience. 14. 31–31. 9 indexed citations

Wang, Rui, Yuko Ishii, Amit Roy, et al.. (2019). Development of a prognostic composite cytokine signature based on the correlation with nivolumab clearance: translational PK/PD analysis in patients with renal cell carcinoma. Journal for ImmunoTherapy of Cancer. 7(1). 348–348. 20 indexed citations

Ali, Md Emran, Yuko Ishii, Sumyya Waliullah, et al.. (2018). Conferring virus resistance in tomato by independent RNA silencing of three tomato homologs of Arabidopsis TOM1. Archives of Virology. 163(5). 1357–1362. 10 indexed citations

10.

Kimura, Ryo, Yuko Ishii, Kiyotaka Tomiwa, et al.. (2018). Williams–Beuren Syndrome as a Potential Risk Factor for Burkitt Lymphoma. Frontiers in Genetics. 9. 368–368. 9 indexed citations

11.

Ishii, Yuko, et al.. (2012). Development of Battery and Charger Integration System (BCIS). 7(1). 24–28. 2 indexed citations

12.

Coupé, Bérengère, Yuko Ishii, Marcelo O. Dietrich, et al.. (2012). Loss of Autophagy in Pro-opiomelanocortin Neurons Perturbs Axon Growth and Causes Metabolic Dysregulation. Cell Metabolism. 15(2). 247–255. 136 indexed citations

13.

Hiraoka, Takahiro, C. Okamoto, Yuko Ishii, et al.. (2009). Patient Satisfaction and Clinical Outcomes After Overnight Orthokeratology. Optometry and Vision Science. 86(7). 875–882. 22 indexed citations

14.

Bouret, Sébastien G., Émilie Caron, Sophie M. Steculorum, Yuko Ishii, & Christelle Sachot. (2008). Leptine et contrôle hypothalamique de la reproduction. 10(2). 74–84. 1 indexed citations

15.

Hiraoka, Takahiro, et al.. (2008). Mesopic Contrast Sensitivity and Ocular Higher-Order Aberrations after Overnight Orthokeratology. American Journal of Ophthalmology. 145(4). 645–655.e1. 40 indexed citations

16.

Hiraoka, Takahiro, Yuko Ishii, Fumiki Okamoto, & Tetsuro Oshika. (2008). Influence of cosmetically tinted soft contact lenses on higher-order wavefront aberrations and visual performance. Graefe s Archive for Clinical and Experimental Ophthalmology. 247(2). 225–233. 10 indexed citations

17.

Ishii, Yuko, Hui‐Hua Hsiao, Goro Sashida, et al.. (2006). Derivative (1;7)(q10;p10) in multiple myeloma. A sign of therapy-related hidden myelodysplastic syndrome. Cancer Genetics and Cytogenetics. 167(2). 131–137. 9 indexed citations

18.

Meister, Björn, et al.. (2006). Hypothalamic proopiomelanocortin (POMC) neurons have a cholinergic phenotype. European Journal of Neuroscience. 24(10). 2731–2740. 62 indexed citations

19.

Kawachi, Ichiro, Takuya Fujieda, Minoru Ujita, et al.. (2001). Purification and Properties of Extracellular Chitinases from the Parasitic Fungus Isaria japonica. Journal of Bioscience and Bioengineering. 92(6). 544–549. 6 indexed citations

20.

Katoh, Etsuko, Tomohisa Hatta, Heisaburo Shindo, et al.. (2000). High precision NMR structure of YhhP, a novel Escherichia coli protein implicated in cell division. Journal of Molecular Biology. 304(2). 219–229. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact